N
Neurocrine Biosciences, Inc. (NBIX)
NMS – Real vaqt narxi. Valyuta: USD
155.80
+5.21 (3.46%)
Yopilishda: May 12, 2026, 4:00 PM EDT
156.57
+0.77 (0.49%)
Bozordan keyin: May 12, 2026, 7:54 PM EDT
Find any stock by ticker or company name

NMS – Real vaqt narxi. Valyuta: USD
155.80
+5.21 (3.46%)
Yopilishda: May 12, 2026, 4:00 PM EDT
156.57
+0.77 (0.49%)
Bozordan keyin: May 12, 2026, 7:54 PM EDT
This stock has a consensus price target of $177.85 based on the ratings of 27 analysts. The high is $242.00 and the low is $140.00.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 140 | $ 177.85 | $ 242 |
| O’zgarish | -7.03% | 18.10% | 60.70% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-04-22 | 8.58% | Leerink Partners | $160 → $170 | Maintains | Outperform |
| 2026-04-10 | 18.16% | Morgan Stanley | $173 → $185 | Maintains | Equal-Weight |
| 2026-04-07 | 54.56% | Citigroup | $204 → $242 | Maintains | Buy |
| 2026-04-07 | 27.74% | Canaccord Genuity | $164 → $200 | Maintains | Buy |
| 2026-04-07 | 6.02% | Wedbush | $151 → $166 | Maintains | Outperform |